Physician profile
Sean Sider
NPI 1215054994
$1,294.11
in general payments reported to CMS, 2019-2025
15 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $44.44 · 2021: $15.47 · 2022: $71.02 · 2023: $393 · 2024: $273 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $397.49 | 2024-2025 | |
| Smith+Nephew, INC. | $164.69 | 2019-2025 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Collaborative Care Diagnostics, LLC | $135.06 | 2019 | |
| Aroa Biosurgery Incorporated | $129.21 | 2023 | |
| Stryker Corporation | $121.94 | 2019-2023 | Anchorage |
| Nevro Corp. | $91.04 | 2022-2024 | Senza |
| Musculoskeletal Transplant Foundation INC. | $77.36 | 2023 | |
| Paratek Pharmaceuticals, INC. | $45.58 | 2024 | Nuzyra |
| Osteomed LLC | $44.44 | 2020 | |
| Sandoz INC. | $17.92 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.98 | 2019 | |
| Abbvie INC. | $15.47 | 2021 | |
| Djo, LLC | $13.43 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.91 | 2019 | |
| Zyla Life Sciences, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Sider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.